projectstartups.com

Neupulse

Neupulse is developing the world's first wearable device to treat Tourette Syndrome and other tic disorders. The device stimulates the median nerve to reduce tic frequency, offering an alternative to medication and therapy. Clinical trials showed a reduction of tics by over 25 percent.


Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $3.2M

Date: 18-Mar-2024

Investors: Eos Advisory, US-based investors

Markets: Medtech, Wearables, Neurology, HealthTech, Digital Health, Monitoring Equipment, Other Healthcare Technology Systems

HQ: Nottingham, Nottinghamshire, United Kingdom

Founded: 2021

Website: https://neupulse.co/

LinkedIn: https://www.linkedin.com/company/neupulse

Twitter: https://twitter.com/neupulseuk

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/neupulse?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase

Pitchbook: https://pitchbook.com/profiles/company/471274-39

Download Funded Startups lists

Leave a Comment